%20CO.%2C%20LTD./other/CHANGCHUN_HIGH-TECH_INDUSTRY_GROUP__inq51an.png)
CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. — Investor Relations & Filings
CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. is a diversified enterprise primarily focused on the research, development, production, and distribution of biopharmaceuticals and healthcare products. The company operates through several key subsidiaries, most notably GeneScience Pharmaceuticals, which specializes in recombinant human growth hormones and pediatric endocrinology treatments. Its product portfolio includes biological drugs, vaccines, and traditional Chinese medicines, targeting therapeutic areas such as growth disorders, infectious diseases, and oncology. The group emphasizes technological innovation and maintains a significant presence in the domestic market while expanding its international footprint. In addition to its core life sciences business, the company maintains interests in real estate development and infrastructure management.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 2024年第一次临时股东大会决议公告 | 2024-02-05 | Chinese | |
| 北京大成(长春)律师事务所关于长春高新技术产业(集团)股份有限公司2024年第一次临时股东大会的法律意见书 | 2024-02-05 | Chinese | |
| 关于2022年限制性股票与股票期权激励计划部分限制性股票注销完成暨调整定向可转债转股价格的公告 | 2024-02-01 | Chinese | |
| 关于首次回购公司股份暨回购结果与股份变动的公告 | 2024-01-25 | Chinese | |
| 关于回购股份事项前十名股东和前十名无限售条件股东持股情况的公告 | 2024-01-22 | Chinese | |
| 回购报告书 | 2024-01-22 | Chinese |
Browse filings by year
27 years- 2026 56 filings
- 2025 176 filings
- 2024 162 filings
- 2023 131 filings
- 2022 139 filings
- 2021 152 filings
- 2020 157 filings
- 2019 238 filings
- 2018 124 filings
- 2017 95 filings
- 2016 102 filings
- 2015 122 filings
- 2014 98 filings
- 2013 75 filings
- 2012 80 filings
- 2011 46 filings
- 2010 57 filings
- 2009 47 filings
- 2008 33 filings
- 2007 42 filings
- 2006 48 filings
- 2005 26 filings
- 2004 29 filings
- 2003 27 filings
- 2002 17 filings
- 2001 7 filings
- 1996 1 filing
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2024
15 filings
| |||||
| 42981245 | 2024年第一次临时股东大会决议公告 | 2024-02-05 | Chinese | ||
| 42981212 | 北京大成(长春)律师事务所关于长春高新技术产业(集团)股份有限公司2024年第一次临时股东大会的法律意见书 | 2024-02-05 | Chinese | ||
| 42981172 | 关于2022年限制性股票与股票期权激励计划部分限制性股票注销完成暨调整定向可转债转股价格的公告 | 2024-02-01 | Chinese | ||
| 42981146 | 关于首次回购公司股份暨回购结果与股份变动的公告 | 2024-01-25 | Chinese | ||
| 42981102 | 关于回购股份事项前十名股东和前十名无限售条件股东持股情况的公告 | 2024-01-22 | Chinese | ||
| 42981081 | 回购报告书 | 2024-01-22 | Chinese | ||
| 42981037 | 关于召开2024年第一次临时股东大会的通知的更正公告 | 2024-01-22 | Chinese | ||
| 42981009 | 第十届董事会第三十二次会议决议公告 | 2024-01-19 | Chinese | ||
| 42980983 | 关于召开2024年第一次临时股东大会的通知 | 2024-01-19 | Chinese | ||
| 42980957 | 关于公司回购股份方案的公告 | 2024-01-19 | Chinese | ||
| 42980924 | 关于控股子公司获得 FDA 药物临床试验默示许可的公告 | 2024-01-16 | Chinese | ||
| 42980896 | 关于控股子公司百克生物披露2023年年度业绩预告的提示性公告 | 2024-01-15 | Chinese | ||
| 42980865 | 第十届董事会第三十一次会议决议公告 | 2024-01-13 | Chinese | ||
| 42980845 | 未来三年(2023-2025年)股东回报规划 | 2024-01-13 | Chinese | ||
| 42980823 | 独立董事专门会议2024年第一次会议审核意见 | 2024-01-13 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/53737/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=53737 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=53737 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=53737 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 53737}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. (id: 53737)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.